EZH2 and ovarian carcinoma: Then the correlation of the key components of two EZH2 pathways EZH2/H3K27Me3 and pAkt1/pS21EZH2 to chemotherapy response, OS and PFS of ovarian cancer patients were assessed independently and in combination.